[CLSTR]
< Back to situations

[ORGANIZATION]

Teva Pharmaceutical Industries

Featured in 6 tracked stories · first seen

Situations

[QUIET] [HEALTH] [US] [FR] [IL]

FDA approval of Weltruza for schizophrenia

2 clusters · 6 sources · last updated

Latest: FDA approves Weltruza monthly subcutaneous olanzapine injection

The U.S. Food and Drug Administration (FDA) has approved Weltruza, a once-monthly subcutaneous olanzapine injection for the treatment of schizophrenia in adults. Developed by Teva Pharmaceutical Industries in partnership

Also covered in